Sedation of horses with romifidine and butorphanol.

The research looks into the effects and efficacy of combining romifidine and butorphanol in sedating horses for various surgical, therapeutic, and diagnostic processes involving 55 horses.

Research Methodology

• The study involved 55 horses which were set to undergo a range of surgical, therapeutic, and diagnostic procedures.
• A combination of two drugs, romifidine and butorphanol, was used to sedate these horses.
• Eighteen horses were administered the drugs separately, introducing romifidine first and following up with butorphanol four minutes later.
• Meanwhile, the remaining 37 horses were administered both drugs simultaneously.

Evaluation and Comparison of Methods

• The study observed the levels of sedation and ataxia (loss of full control of bodily movements) in the horses after the administration of the drugs.
• The research noticed no statistically significant disparities in the sedation and ataxia levels between the two modes of drug administration. This suggests that administering the drugs together did not negatively affect or enhance the sedation process opposed to when the drugs were administered separately.

Observation of Side Effects

• Typical side effects of alpha-2 agonists were observed, including slowed-down heartbeats (bradycardia), heart block issues, and some amount of sweating.
• One horse was noted to have developed box-walking, a compulsive walking behavior seen in horses due to stress or confinement. This could indicate stress from being sedated or undergoing a surgical, therapeutic, or diagnostic procedure.

Overall Findings and Conclusion

• The procedures were successfully completed in 54 of the horses, signaling the efficiency of the combination of romifidine and butorphanol in serving as a sedate for horses.
• The combination of drugs was determined to be safe and effective, making it a reliable sedative option for horses undergoing various treatments and procedures.